Thor Therapeutics

Thor Therapeutics is a developer of cancer cachexia treatments.

Latest funding

Series A · November 1, 2026

Amount not disclosed in a source on record.

Website: thortherapeutics.com.

Categories: Health and bio Developer tools and cloud.

Sectors: Biotechnology, Oncology, Therapeutics.

Stage: Series A.

Based in: Seongnam, South Korea.

Last round: Nov 1, 2026 · 11 days ago.

On Recent Funding since: Nov 4, 2026.

Signals

Website registeredJan 24, 2022 (4 years old)

November 1, 2026
Series A · amount undisclosed
AAlteogen, TThe Iroun Partners
Source: wowtale.net
January 24, 2022
Website created

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/thor-therapeutics (get a free API key).